149 related articles for article (PubMed ID: 35321940)
1. Immunosuppressant Medication Use in Patients with Kidney Allograft Failure: A Prospective Multicenter Canadian Cohort Study.
Knoll G; Campbell P; Chassé M; Fergusson D; Ramsay T; Karnabi P; Perl J; House AA; Kim J; Johnston O; Mainra R; Houde I; Baran D; Treleaven DJ; Senecal L; Tibbles LA; Hébert MJ; White C; Karpinski M; Gill JS
J Am Soc Nephrol; 2022 Jun; 33(6):1182-1192. PubMed ID: 35321940
[TBL] [Abstract][Full Text] [Related]
2. Plasma Lead Concentration and Risk of Late Kidney Allograft Failure: Findings From the TransplantLines Biobank and Cohort Studies.
Sotomayor CG; Giubergia F; Groothof D; Ferreccio C; Nolte IM; Navis GJ; Gomes-Neto AW; Kremer D; Knobbe TJ; Eisenga MF; Rodrigo R; Touw DJ; Bakker SJL;
Am J Kidney Dis; 2022 Jul; 80(1):87-97.e1. PubMed ID: 34871698
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of Recipients With 10 or More Years of Allograft Survival in Deceased Donor Kidney Transplantation.
Kang SS; Park WY; Jin K; Park SB; Han S
Transplant Proc; 2018 May; 50(4):1013-1017. PubMed ID: 29731058
[TBL] [Abstract][Full Text] [Related]
4. Pretransplant Calculated Panel Reactive Antibody in the Absence of Donor-Specific Antibody and Kidney Allograft Survival.
Lan JH; Kadatz M; Chang DT; Gill J; Gebel HM; Gill JS
Clin J Am Soc Nephrol; 2021 Feb; 16(2):275-283. PubMed ID: 33495290
[TBL] [Abstract][Full Text] [Related]
5. Review: Management of patients with kidney allograft failure.
Bunthof KLW; Hazzan M; Hilbrands LB
Transplant Rev (Orlando); 2018 Jul; 32(3):178-186. PubMed ID: 29628415
[TBL] [Abstract][Full Text] [Related]
6. Factors at de novo donor-specific antibody initial detection associated with allograft loss: a multicenter study.
Schinstock CA; Dadhania DM; Everly MJ; Smith B; Gandhi M; Farkash E; Sharma VK; Samaniego-Picota M; Stegall MD
Transpl Int; 2019 May; 32(5):502-515. PubMed ID: 30597643
[TBL] [Abstract][Full Text] [Related]
7. Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft.
Grinyó JM; Gil-Vernet S; Seron D; Hueso M; Fulladosa X; Cruzado JM; Moreso F; Fernandez A; Torras J; Riera L; Castelao AM; Alsina J
Nephrol Dial Transplant; 1998 Oct; 13(10):2601-4. PubMed ID: 9794567
[TBL] [Abstract][Full Text] [Related]
8. Variation in Dialysis Exposure Prior to Nonpreemptive Living Donor Kidney Transplantation in the United States and Its Association With Allograft Outcomes.
Gill JS; Rose C; Joffres Y; Landsberg D; Gill J
Am J Kidney Dis; 2018 May; 71(5):636-647. PubMed ID: 29395484
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppression management in renal transplant recipients with normal-immunological risk: 10-year results from the Swiss Transplant Cohort Study.
Krisl A; Stampf S; Hauri D; Binet I; Mueller T; Sidler D; Hadaya K; Golshayan D; Pascual M; Koller M; Dickenmann M; The Swiss Transplant Cohort Study Stcs
Swiss Med Wkly; 2020 Nov; 150():w20354. PubMed ID: 33277913
[TBL] [Abstract][Full Text] [Related]
10. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.
Woodroffe R; Yao GL; Meads C; Bayliss S; Ready A; Raftery J; Taylor RS
Health Technol Assess; 2005 May; 9(21):1-179, iii-iv. PubMed ID: 15899149
[TBL] [Abstract][Full Text] [Related]
11. Development of de novo HLA donor specific antibodies (HLA-DSA), HLA antibodies (HLA-Ab) and allograft rejection post blood transfusion in kidney transplant recipients.
Jalalonmuhali M; Carroll RP; Tsiopelas E; Clayton P; Coates PT
Hum Immunol; 2020 Jul; 81(7):323-329. PubMed ID: 32327243
[TBL] [Abstract][Full Text] [Related]
12. Differences in Pathologic Features and Graft Outcomes of Rejection on Kidney Transplant.
Park WY; Paek JH; Jin K; Park SB; Choe M; Han S
Transplant Proc; 2019 Oct; 51(8):2655-2659. PubMed ID: 31345597
[TBL] [Abstract][Full Text] [Related]
13. Economic analysis of basiliximab in renal transplantation.
Keown PA; Balshaw R; Krueger H; Baladi JF
Transplantation; 2001 Jun; 71(11):1573-9. PubMed ID: 11435967
[TBL] [Abstract][Full Text] [Related]
14. Pre-transplant HLA Antibodies and Delayed Graft Function in the Current Era of Kidney Transplantation.
Morath C; Döhler B; Kälble F; Pego da Silva L; Echterdiek F; Schwenger V; Živčić-Ćosić S; Katalinić N; Kuypers D; Benöhr P; Haubitz M; Ziemann M; Nitschke M; Emmerich F; Pisarski P; Karakizlis H; Weimer R; Ruhenstroth A; Scherer S; Tran TH; Mehrabi A; Zeier M; Süsal C
Front Immunol; 2020; 11():1886. PubMed ID: 32983110
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of Kidney Transplantation Abroad: A Single-Center Canadian Cohort Study.
Quach K; Sultan H; Li Y; Famure O; Kim SJ
Prog Transplant; 2016 Mar; 26(1):5-12. PubMed ID: 27136244
[TBL] [Abstract][Full Text] [Related]
16. Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients.
Lefaucheur C; Viglietti D; Bouatou Y; Philippe A; Pievani D; Aubert O; Duong Van Huyen JP; Taupin JL; Glotz D; Legendre C; Loupy A; Halloran PF; Dragun D
Kidney Int; 2019 Jul; 96(1):189-201. PubMed ID: 31005275
[TBL] [Abstract][Full Text] [Related]
17. Fever, infection, and rejection after kidney transplant failure.
Woodside KJ; Schirm ZW; Noon KA; Huml AM; Padiyar A; Sanchez EQ; Sarabu N; Hricik DE; Schulak JA; Augustine JJ
Transplantation; 2014 Mar; 97(6):648-53. PubMed ID: 24637864
[TBL] [Abstract][Full Text] [Related]
18. Allograft outcome following repeat transplantation of patients with non-adherence-related first kidney allograft failure: a population cohort study.
Manickavasagar R; Wong G; Alexander SI; Francis A; Prestidge C; Larkins NG; Le Page A; Lim WH
Transpl Int; 2019 Dec; 32(12):1247-1258. PubMed ID: 31408545
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Psychoeducational Intervention on Allograft Function in Kidney Transplant Patients: 10-Year Results of a Prospective Randomized Study.
Breu-Dejean N; Driot D; Dupouy J; Lapeyre-Mestre M; Rostaing L
Exp Clin Transplant; 2016 Feb; 14(1):38-44. PubMed ID: 26862823
[TBL] [Abstract][Full Text] [Related]
20. Transplanting Sensitized Kidney Transplant Patients With Equivalent Outcomes Utilizing Stringent HLA Crossmatching.
Rohan VS; Taber DJ; Moussa O; Pilch NA; Denmark S; Meadows HB; McGillicuddy JW; Chavin KD; Baliga PK; Bratton CF
Exp Clin Transplant; 2017 Feb; 15(1):47-55. PubMed ID: 27267614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
